Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Podcast: Challenges in the Development and Manufacturing of ADCs

Explore smart strategies for overcoming ADC development and manufacturing challenges. Find your way forward in this exciting, evolving area. Listen now as experts from Olon Group share their insights with Citeline. Listen now, and explore topics including:

• How ADCs are transforming the pharma industry
• Overcoming critical technical challenges in ADC manufacturing and ADC purification across the value chain
• Leveraging Design of Experiments (DoE) advantages in the chemical development of ADCs
• Outsourcing all parts of ADC manufacturing to a single CDMO: pros and cons
• New and unique ADC capabilities at Olon
• Emerging and future challenges for ADCs

 

 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC150951

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel